Dr Paula Kovarik, MD - Medicare Pathology in Chicago, IL

Dr Paula Kovarik, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Chicago, Illinois. Her current practice location is 1901 W Harrison St, Chicago, Illinois. You can reach out to her office (for appointments etc.) via phone at (312) 864-7435.

Dr Paula Kovarik is licensed to practice in Illinois (license number 36081797) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1225156730.

Contact Information

Dr Paula Kovarik, MD
1901 W Harrison St,
Chicago, IL 60612-3714
(312) 864-7435
(312) 864-9860



Physician's Profile

Full NameDr Paula Kovarik
GenderFemale
SpecialityPathology - Anatomic Pathology & Clinical Pathology
Location1901 W Harrison St, Chicago, Illinois
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1225156730
  • Provider Enumeration Date: 03/26/2007
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 6800077231
  • Enrollment ID: I20110218000098

Medical Identifiers

Medical identifiers for Dr Paula Kovarik such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1225156730NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 36081797 (Illinois)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Paula Kovarik allows following entities to bill medicare on her behalf.
Entity NameCook County
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588612832
PECOS PAC ID: 2860398088
Enrollment ID: O20031209000747

News Archive

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

Cyclacel second-quarter net loss decreases to $6.5 million

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.

Administration moving the 'right way' by emphasizing global health coordination at country levels

The recent announcement "that the Administration's signature Global Health Initiative (GHI) was being replaced by a new Office of Global Health Diplomacy at State was greeted with withering criticism from many in the global health community," PSI CEO Karl Hofmann writes in this post in the organization's "Healthy Lives" blog.

UPMC study gives better understanding of cardiac arrhythmia following lung transplantation

Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival, reports a team of UPMC researchers in the largest study of its kind to date.

Read more Medical News

› Verified 9 days ago

Entity NameFox Valley Laboratory Physicians Sc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1841223963
PECOS PAC ID: 1254377146
Enrollment ID: O20050630000600

News Archive

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

Cyclacel second-quarter net loss decreases to $6.5 million

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.

Administration moving the 'right way' by emphasizing global health coordination at country levels

The recent announcement "that the Administration's signature Global Health Initiative (GHI) was being replaced by a new Office of Global Health Diplomacy at State was greeted with withering criticism from many in the global health community," PSI CEO Karl Hofmann writes in this post in the organization's "Healthy Lives" blog.

UPMC study gives better understanding of cardiac arrhythmia following lung transplantation

Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival, reports a team of UPMC researchers in the largest study of its kind to date.

Read more Medical News

› Verified 9 days ago

Entity NameMidwest Diagnostic Pathology, S.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1982606380
PECOS PAC ID: 7911924428
Enrollment ID: O20051024001038

News Archive

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

Cyclacel second-quarter net loss decreases to $6.5 million

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.

Administration moving the 'right way' by emphasizing global health coordination at country levels

The recent announcement "that the Administration's signature Global Health Initiative (GHI) was being replaced by a new Office of Global Health Diplomacy at State was greeted with withering criticism from many in the global health community," PSI CEO Karl Hofmann writes in this post in the organization's "Healthy Lives" blog.

UPMC study gives better understanding of cardiac arrhythmia following lung transplantation

Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival, reports a team of UPMC researchers in the largest study of its kind to date.

Read more Medical News

› Verified 9 days ago

Entity NameMchenry Pathology Associates Sc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942669478
PECOS PAC ID: 4688970007
Enrollment ID: O20160311000232

News Archive

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

Cyclacel second-quarter net loss decreases to $6.5 million

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.

Administration moving the 'right way' by emphasizing global health coordination at country levels

The recent announcement "that the Administration's signature Global Health Initiative (GHI) was being replaced by a new Office of Global Health Diplomacy at State was greeted with withering criticism from many in the global health community," PSI CEO Karl Hofmann writes in this post in the organization's "Healthy Lives" blog.

UPMC study gives better understanding of cardiac arrhythmia following lung transplantation

Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival, reports a team of UPMC researchers in the largest study of its kind to date.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Paula Kovarik is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Paula Kovarik, MD
1139 S East Ave,
Oak Park, IL 60304-2105

Ph: (708) 386-6801
Dr Paula Kovarik, MD
1901 W Harrison St,
Chicago, IL 60612-3714

Ph: (312) 864-7435

News Archive

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

Cyclacel second-quarter net loss decreases to $6.5 million

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.

Administration moving the 'right way' by emphasizing global health coordination at country levels

The recent announcement "that the Administration's signature Global Health Initiative (GHI) was being replaced by a new Office of Global Health Diplomacy at State was greeted with withering criticism from many in the global health community," PSI CEO Karl Hofmann writes in this post in the organization's "Healthy Lives" blog.

UPMC study gives better understanding of cardiac arrhythmia following lung transplantation

Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival, reports a team of UPMC researchers in the largest study of its kind to date.

Read more News

› Verified 9 days ago


Pathology Doctors in Chicago, IL

Mark Wang, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611
Phone: 312-503-8144    Fax: 312-502-8249
Sandeep Gurbuxani,
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 5841 S Maryland Ave, Chicago, IL 60637
Phone: 888-824-0200    
Dr. Katrina Krogh, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 251 E Huron St Ste 7-132i, Chicago, IL 60611
Phone: 312-926-7913    Fax: 312-926-3127
Dr. Carmencita Garcia Senseng, MD
Pathology
Medicare: Medicare Enrolled
Practice Location: 1900 W Polk St, Chicago, IL 60612
Phone: 312-864-7561    
Suman Setty,
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 1740 W Taylor St, Chicago, IL 60612
Phone: 866-600-2273    
Jayme Brentan, MD
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611
Phone: 312-695-9797    
Dr. Megan Elizabeth Sullivan, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611
Phone: 312-926-3211    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.